MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$112,899K
Cash and cash
equivalents
$71,317K
Inventory, net
$1,826K
Accounts receivable, net
$1,605K
License receivable
$1,546K
Other receivables
$1,425K
Prepaid expenses
$1,210K
Research and development
tax credits...
$425K
Total current assets
$192,253K
Operating lease
right-of-use assets
$981K
Property and equipment,
net
$500K
Total assets
$193,734K
Total liabilities and
shareholders' equity
$193,734K
Total liabilities
$157,685K
Total shareholders'
equity
$36,049K
Accumulated deficit
-$456,669K
Royalty financing
obligation, long-term
$78,111K
Senior secured
convertible notes
$58,192K
Total current
liabilities
$20,944K
Operating lease
liabilities, net of current...
$366K
Other long-term
liabilities
$72K
Common shares, no par
value, unlimited...
$373,702K
Additional paid-in capital
$63,367K
Pre-funded warrants -
16,412,925 issued and...
$55,649K
Accounts payable
$10,023K
Accrued liabilities
$9,803K
Operating lease
liabilities
$659K
Deferred revenue
$416K
Other current
liabilities
$43K
Back
Back
Balance Sheet
source: myfinsight.com
Milestone Pharmaceuticals Inc. (MIST)
Milestone Pharmaceuticals Inc. (MIST)